Bruin, Maaike A. C.
Mohmaed Ali, Ma Ida http://orcid.org/0000-0002-6853-6763
van Nuland, Merel
Jacobs, Bart A. W.
Lucas, Luc
Dezentje, Vincent O.
de Feijter, Jeantine M.
Rosing, Hilde
Bergman, Andries M.
Beijnen, Jos H.
Huitema, Alwin D. R.
Article History
Received: 21 July 2023
Accepted: 27 September 2023
First Online: 11 October 2023
Declarations
:
: M.A.C. Bruin, M.I. Mohmaed Ali, M. van Nuland, B.A.W. Jacobs, L. Lucas, H. Rosing and A.D.R. Huitema: declare they have no conflict of interest to report.V.O. Dezentje attended advisory boards for Novartis, Astra Zeneca / Daiichy Sankyo. This all is not related to the submitted manuscript.J.M. de Feijter attended advisory boards for Janssen and Bayer. Received reimbursement of travel expenses from Merkc / Pzizer. This all is not related to the submitted manuscript.A.M. Bergman received grants, contracts, or consulting fees from Bayer, Sanofi, Astellas. This all is not related to the submitted manuscript.J.H. Beijnen is a part-time employee and (indirect) stock holder of Modra Pharmaceuticals BV (Amsterdam), a small spin out company of the Netherlands Cancer Institute developing oral taxane treatments. He is also a co-inventor on a patent of oral taxane formulations. This all is not related to the submitted manuscript.